| ID | 10021 |
| Vaccine Name | Gam-COVID-Vac |
| Disease Name | COVID-19 |
| Disease Classification | Respiratory |
| Virus Name | SARS-CoV-2 virus |
| Nucleic Acid Content | positive-sense, single-stranded RNA |
| Vaccine Type | Recombinant viral vector |
| Vaccine Status | Approved |
| Manufacturer | Gamaleya Research Institute of Epidemiology and Microbiology |
| Year of Manufacturing | NA |
| Manufacturing Country | Russia |
| Age | NA |
| Dosage | 2 doses 3 weeks apart |
| Administration Route | Intramuscular |
| Adjuvant | NA |
| Target Strain | NA |
| Description | NA |
| Approving Organisation | US FDA |
| Collaborating Organisation | Health Ministry of the Russian Federation |
| Other Countries | Russia, Bolivia, Argentina, Algeria, Serbia, Belarus |
| Trade Name | Sputnik-V |
| PMID | NA |
| Clinical Trial ID | NA |
| Reference Link | https://www.precisionvaccinations.com/vaccines/sputnik-v-vaccine |
| Additional Links | NA
|